Literature DB >> 28816027

Estimation of live birth and population prevalence of Down syndrome in nine U.S. states.

Gert de Graaf1, Frank Buckley2,3, Jennifer Dever4, Brian G Skotko4,5.   

Abstract

For all of the U.S. states with sufficient data, we estimated live birth and population prevalences for Down syndrome (DS). As social service resources vary between states, such data are important for public policy discussions and state planning. We predicted the actual and nonselective live birth prevalence, and population prevalence, for DS in nine U.S. states based on publicly available datasets from the Centers for Disease Control and Prevention and the Integrated Public Use Microdata Series. As of 2010, we estimated a population size for people with DS of 4,554 in MA (population prevalence 1 in 1,440), 6,101 in NJ (1 in 1,443), 14,315 in NY (1 in 1,355), 9,739 in IL (1 in 1,319), 4,354 in IN (1 in 1,491), 7,295 in MI (1 in 1,354), 9,099 in FL (1 in 2,071), 3,014 in KY (1 in 1,442), and 3,596 in AZ (1 in 1,784). The number of people living with DS has steadily increased from 1950 until 2010 in these nine U.S. states. Population prevalence would have been higher absent DS-related elective terminations. Racial and ethnic groups, other than non-Hispanic whites, comprise a growing proportion within these DS communities, particularly among younger-aged persons.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Down syndrome; epidemiology; health policy; population health; prevalence; trisomy 21

Mesh:

Year:  2017        PMID: 28816027     DOI: 10.1002/ajmg.a.38402

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  13 in total

1.  Better beings?

Authors:  Amber Dance
Journal:  Nat Biotechnol       Date:  2017-11-09       Impact factor: 54.908

2.  Is the Autism Boom Headed for Medicaid? Patterns in the Enrollment of Autistic Adults in Wisconsin Medicaid, 2008-2018.

Authors:  Eric Rubenstein; Lauren Bishop
Journal:  Autism Res       Date:  2019-07-17       Impact factor: 5.216

3.  Defining Expressive Language Benchmarks for Children with Down Syndrome.

Authors:  Angela John Thurman; Lauren Bullard; Leona Kelly; Caitlyn Wong; Vivian Nguyen; Anna J Esbensen; Jennifer Bekins; Emily K Schworer; Deborah J Fidler; Lisa A Daunhauer; Carolyn B Mervis; C Holley Pitts; Angela M Becerra; Leonard Abbeduto
Journal:  Brain Sci       Date:  2022-06-06

Review 4.  Alzheimer's disease associated with Down syndrome: a genetic form of dementia.

Authors:  Juan Fortea; Shahid H Zaman; Sigan Hartley; Michael S Rafii; Elizabeth Head; Maria Carmona-Iragui
Journal:  Lancet Neurol       Date:  2021-11       Impact factor: 59.935

Review 5.  Beyond amyloid: Immune, cerebrovascular, and metabolic contributions to Alzheimer disease in people with Down syndrome.

Authors:  Alessandra C Martini; Thomas J Gross; Elizabeth Head; Mark Mapstone
Journal:  Neuron       Date:  2022-04-25       Impact factor: 18.688

6.  Evaluating working memory outcome measures for children with Down syndrome.

Authors:  E K Schworer; A J Esbensen; D J Fidler; D W Beebe; A Carle; S Wiley
Journal:  J Intellect Disabil Res       Date:  2021-03-25

7.  Genetic Basis of Human Congenital Heart Disease.

Authors:  Shannon N Nees; Wendy K Chung
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-09-01       Impact factor: 9.708

8.  Novel insights from fetal and placental phenotyping in 3 mouse models of Down syndrome.

Authors:  April D Adams; Victoria Hoffmann; Laura Koehly; Faycal Guedj; Diana W Bianchi
Journal:  Am J Obstet Gynecol       Date:  2021-03-22       Impact factor: 10.693

9.  Prevalence of Down's Syndrome in England, 1998-2013: Comparison of linked surveillance data and electronic health records.

Authors:  J C Doidge; J K Morris; K L Harron; S Stevens; R Gilbert
Journal:  Int J Popul Data Sci       Date:  2020-03-19

10.  Down syndrome with co-occurring Marfan syndrome.

Authors:  Miao Wei; Natasha Lepore; Kelli Paulsen; Jonathan D Santoro
Journal:  BMJ Case Rep       Date:  2020-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.